Category - Executive Moves

Executive Moves

Elemer Piros rejoins Roth healthcare research team

Elemer Piros Elemer Piros has rejoined the healthcare research team at Roth Capital Partners as managing director, senior research analyst covering biotechnology. His research coverage is expected to include small...

July 9, 2020

Executive Moves

Strongbridge Biopharma names John Johnson as CEO

John Johnson Strongbridge Biopharma (NASDAQ:SBBP) appointed its executive chairman, John Johnson, as the company’s CEO, effective immediately. Mr. Johnson served as Strongbridge’s chairman since March 2015. In...

July 7, 2020

Executive Moves

Chimerix appoints Allen Melemed as CMO

Allen Melemed Chimerix (NASDAQ:CMRX) appointed Dr. Allen Melemed as its CMO. Dr. Melemed was most recently a distinguished medical fellow and senior director of North American regulatory affairs oncology at Eli Lilly...

June 22, 2020

Executive Moves

NeuroOne appoints neural engineering expert, Camilo Andres Diaz-Botia, as director of electrode development

Camilo Andres Diaz-Botia NeuroOne Medical Technologies (OTCQB:NMTC) appointed neural engineer, Camilo Andres Diaz-Botia, as director of electrode development. Dr. Diaz-Botia previously led the microfabrication process...

June 17, 2020

Executive Moves

Hepion names drug development expert, Dr. Peter Wijngaard, to its board

Peter Wijngaard Hepion Pharmaceuticals (NASDAQ:HEPA) appointed industry veteran, Dr. Peter Wijngaard, to its board of directors. “Dr. Wijngaard provided invaluable guidance to Hepion’s management team during our earlier...

June 10, 2020

Executive Moves

AMAG Pharma appoints Scott Myers as president and CEO

AMAG Pharmaceuticals (NASDAQ:AMAG) appointed Scott Myers as its president and CEO, and a member of the board, effective immediately. Mr. Myers was most recently chairman and CEO of Rainier Therapeutics. He replaces...

April 28, 2020

Executive Moves

PharmaJet appoints Chris Cappello as president and CEO

Chris Cappello Closely-held PharmaJet appointed Chris Cappello as its president and CEO, replacing Ron Lowy, who was appointed as executive chairman. “In the 10 years that [Mr.Cappello] has worked for PharmaJet, he has...

April 28, 2020

Executive Moves

TerrAscend appoints Jason Ackerman as permanent CEO; CFO to step down

Jason Ackerman TerrAscend (OTCQX:TRSSF) appointed Jason Ackerman as CEO and reported that its CFO, Adam Kozak, will step down as the company relocates its financial operations from Toronto to New York City. Mr. Ackerman...

April 14, 2020

Executive Moves

Five Prime Therapeutics appoints industry leader, Tom Civik, as CEO

Tom Civik Five Prime Therapeutics (NASDAQ:FPRX) appointed Tom Civik as president, CEO and a director. William Ringo, who served as Five Prime’s chairman and interim CEO since September 2019, will step down as CEO and...

April 14, 2020

Executive Moves

Akcea names Damien Devitt as CEO

Damien Devitt, who has been interim CEO of Akcea Therapeutics (NASDAQ:AKCA) since September 2019, has been promoted to CEO, effective immediately, and will continue to serve as a member of Akcea’s board. “With his...

March 24, 2020

Category - Executive Moves

Elemer Piros rejoins Roth healthcare research team

Strongbridge Biopharma names John Johnson as CEO

Chimerix appoints Allen Melemed as CMO

NeuroOne appoints neural engineering expert, Camilo Andres Diaz-Botia, as director of electrode development

Hepion names drug development expert, Dr. Peter Wijngaard, to its board

AMAG Pharma appoints Scott Myers as president and CEO

PharmaJet appoints Chris Cappello as president and CEO

TerrAscend appoints Jason Ackerman as permanent CEO; CFO to step down

Five Prime Therapeutics appoints industry leader, Tom Civik, as CEO

Akcea names Damien Devitt as CEO

General

More